Scandinavian trial of Uncomplicated Aortic Dissection Therapy
The SUNDAY Trial is a randomized study evaluating whether adding TEVAR to standard therapy improves five-year survival in uncomplicated type-B aortic dissection. Secondary outcomes include mortality, neurological events, quality of life, costs, and reinterventions. Subgroup analyses will assess treatment extent.
In the “Events” section, you’ll find information on upcoming meetings, conferences, and workshops relevant to the SUNDAY Trial and its participants. Stay informed about opportunities for professional collaboration, presentation of new research findings, and networking with colleagues across the Nordic region and Europe. We update this section regularly to ensure you don’t miss important dates in aortic research and treatment.
Read more about all our upcoming events here:
